Datawatch (DWCH) Alert: Johnson Fistel Investigates Proposed Sale of Datawatch Corporation to Altair; Are Shareholders Getting a Fair Deal?
NEWS PROVIDED BY
(Johnson Fistel, LLP)
SAN DIEGO, Nov. 5, 2018 /PRNewswire/ — Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Datawatch Corporation (NASDAQ: DWCH) (“Datawatch”) breached their fiduciary duties in connection with the proposed sale of the Company to Altair (NASDAQ: ALTR).
On November 5, 2018, Datawatch announced that it had signed a definitive merger agreement with Altair. Under the terms of the merger agreement, Altair will pay $13.10 per share in cash.
The investigation concerns whether the Datawatch board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for Datawatch shares of common stock. Nationally recognized Johnson Fistel is investigating whether the proposed deal represents adequate consideration, especially given Wall Street analysts’ projections for future revenue growth. Additionally, one Wall Street analyst has a $22.00 price target on the stock. The 52-week high for Datawatch was $14.20.
If you are a shareholder of Datawatch and believe the proposed buyout price is too low or you’re interested in learning more about the investigation or your legal rights and remedies, please contact lead analyst Jim Baker (firstname.lastname@example.org) at 619-814-4471. If emailing, please include a phone number.
Additionally, you can [click here to join this action].There is no cost or obligation to you.
About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York, and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit https://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.
Johnson Fistel, LLP
Jim Baker, 619-814-4471
SOURCE Johnson Fistel, LLP
I am a Clinical Lab Scientist, entrepreneur, investor and trader (stocks and Forex). I enjoy writing and publishing articles online.